Copyright Reports & Markets. All rights reserved.

Global Drug–Device Combination Products Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Drug–Device Combination Products Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Drug–Device Combination Products Market Size Growth Rate by Product
      • 1.4.2 Infusion Pumps
      • 1.4.3 Orthopedic Combination Products
      • 1.4.4 Photodynamic Therapy Devices
      • 1.4.5 Transdermal Patches
      • 1.4.6 Drug Eluting Stents
      • 1.4.7 Wound Care Products
      • 1.4.8 Inhalers
      • 1.4.9 Other
    • 1.5 Market by End User
      • 1.5.1 Global Drug–Device Combination Products Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Drug–Device Combination Products Market Size
      • 2.1.1 Global Drug–Device Combination Products Revenue 2014-2025
      • 2.1.2 Global Drug–Device Combination Products Sales 2014-2025
    • 2.2 Drug–Device Combination Products Growth Rate by Regions
      • 2.2.1 Global Drug–Device Combination Products Sales by Regions
      • 2.2.2 Global Drug–Device Combination Products Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Drug–Device Combination Products Sales by Manufacturers
      • 3.1.1 Drug–Device Combination Products Sales by Manufacturers
      • 3.1.2 Drug–Device Combination Products Sales Market Share by Manufacturers
      • 3.1.3 Global Drug–Device Combination Products Market Concentration Ratio (CR5 and HHI)
    • 3.2 Drug–Device Combination Products Revenue by Manufacturers
      • 3.2.1 Drug–Device Combination Products Revenue by Manufacturers (2014-2019)
      • 3.2.2 Drug–Device Combination Products Revenue Share by Manufacturers (2014-2019)
    • 3.3 Drug–Device Combination Products Price by Manufacturers
    • 3.4 Drug–Device Combination Products Manufacturing Base Distribution, Product Types
      • 3.4.1 Drug–Device Combination Products Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Drug–Device Combination Products Product Type
      • 3.4.3 Date of International Manufacturers Enter into Drug–Device Combination Products Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Drug–Device Combination Products Sales by Product
    • 4.2 Global Drug–Device Combination Products Revenue by Product
    • 4.3 Drug–Device Combination Products Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Drug–Device Combination Products Breakdown Data by End User

    6 North America

    • 6.1 North America Drug–Device Combination Products by Countries
      • 6.1.1 North America Drug–Device Combination Products Sales by Countries
      • 6.1.2 North America Drug–Device Combination Products Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Drug–Device Combination Products by Product
    • 6.3 North America Drug–Device Combination Products by End User

    7 Europe

    • 7.1 Europe Drug–Device Combination Products by Countries
      • 7.1.1 Europe Drug–Device Combination Products Sales by Countries
      • 7.1.2 Europe Drug–Device Combination Products Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Drug–Device Combination Products by Product
    • 7.3 Europe Drug–Device Combination Products by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Drug–Device Combination Products by Countries
      • 8.1.1 Asia Pacific Drug–Device Combination Products Sales by Countries
      • 8.1.2 Asia Pacific Drug–Device Combination Products Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Drug–Device Combination Products by Product
    • 8.3 Asia Pacific Drug–Device Combination Products by End User

    9 Central & South America

    • 9.1 Central & South America Drug–Device Combination Products by Countries
      • 9.1.1 Central & South America Drug–Device Combination Products Sales by Countries
      • 9.1.2 Central & South America Drug–Device Combination Products Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Drug–Device Combination Products by Product
    • 9.3 Central & South America Drug–Device Combination Products by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Drug–Device Combination Products by Countries
      • 10.1.1 Middle East and Africa Drug–Device Combination Products Sales by Countries
      • 10.1.2 Middle East and Africa Drug–Device Combination Products Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Drug–Device Combination Products by Product
    • 10.3 Middle East and Africa Drug–Device Combination Products by End User

    11 Company Profiles

    • 11.1 Abbott
      • 11.1.1 Abbott Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Abbott Drug–Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Abbott Drug–Device Combination Products Products Offered
      • 11.1.5 Abbott Recent Development
    • 11.2 Terumo Corporation
      • 11.2.1 Terumo Corporation Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Terumo Corporation Drug–Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Terumo Corporation Drug–Device Combination Products Products Offered
      • 11.2.5 Terumo Corporation Recent Development
    • 11.3 Stryker Corporation
      • 11.3.1 Stryker Corporation Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Stryker Corporation Drug–Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Stryker Corporation Drug–Device Combination Products Products Offered
      • 11.3.5 Stryker Corporation Recent Development
    • 11.4 Mylan
      • 11.4.1 Mylan Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Mylan Drug–Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Mylan Drug–Device Combination Products Products Offered
      • 11.4.5 Mylan Recent Development
    • 11.5 Medtronic
      • 11.5.1 Medtronic Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Medtronic Drug–Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Medtronic Drug–Device Combination Products Products Offered
      • 11.5.5 Medtronic Recent Development
    • 11.6 Allergan
      • 11.6.1 Allergan Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Allergan Drug–Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Allergan Drug–Device Combination Products Products Offered
      • 11.6.5 Allergan Recent Development
    • 11.7 Boston Scientific
      • 11.7.1 Boston Scientific Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Boston Scientific Drug–Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Boston Scientific Drug–Device Combination Products Products Offered
      • 11.7.5 Boston Scientific Recent Development
    • 11.8 Novartis
      • 11.8.1 Novartis Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Novartis Drug–Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Novartis Drug–Device Combination Products Products Offered
      • 11.8.5 Novartis Recent Development
    • 11.9 C.R. Bard
      • 11.9.1 C.R. Bard Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 C.R. Bard Drug–Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 C.R. Bard Drug–Device Combination Products Products Offered
      • 11.9.5 C.R. Bard Recent Development
    • 11.10 Teleflex Incorporated
      • 11.10.1 Teleflex Incorporated Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Teleflex Incorporated Drug–Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Teleflex Incorporated Drug–Device Combination Products Products Offered
      • 11.10.5 Teleflex Incorporated Recent Development

    12 Future Forecast

    • 12.1 Drug–Device Combination Products Market Forecast by Regions
      • 12.1.1 Global Drug–Device Combination Products Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Drug–Device Combination Products Revenue Forecast by Regions 2019-2025
    • 12.2 Drug–Device Combination Products Market Forecast by Product
      • 12.2.1 Global Drug–Device Combination Products Sales Forecast by Product 2019-2025
      • 12.2.2 Global Drug–Device Combination Products Revenue Forecast by Product 2019-2025
    • 12.3 Drug–Device Combination Products Market Forecast by End User
    • 12.4 North America Drug–Device Combination Products Forecast
    • 12.5 Europe Drug–Device Combination Products Forecast
    • 12.6 Asia Pacific Drug–Device Combination Products Forecast
    • 12.7 Central & South America Drug–Device Combination Products Forecast
    • 12.8 Middle East and Africa Drug–Device Combination Products Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Drug–Device Combination Products Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Combination products are therapeutic and diagnostic products that combine drugs, devices, and/or biological products. 
      The global Drug–Device Combination Products market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Drug–Device Combination Products market based on company, product type, end user and key regions.

      This report studies the global market size of Drug–Device Combination Products in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drug–Device Combination Products in these regions.
      This research report categorizes the global Drug–Device Combination Products market by top players/brands, region, type and end user. This report also studies the global Drug–Device Combination Products market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Abbott
      Terumo Corporation
      Stryker Corporation
      Mylan
      Medtronic
      Allergan
      Boston Scientific
      Novartis
      C.R. Bard
      Teleflex Incorporated

      Market size by Product
      Infusion Pumps
      Orthopedic Combination Products
      Photodynamic Therapy Devices
      Transdermal Patches
      Drug Eluting Stents
      Wound Care Products
      Inhalers
      Other
      Market size by End User
      Hospital
      Clinic
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Drug–Device Combination Products market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Drug–Device Combination Products market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Drug–Device Combination Products companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Drug–Device Combination Products submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Drug–Device Combination Products are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drug–Device Combination Products market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now